The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Role Of Lipids In Brain Injury And Diseases
Open accessAbstract
Lipid metabolism is of particular interest due to its high concentration in CNS. The importance of lipids in cell signaling and tissue physiology is demonstrated by many CNS disorders and injuries that involve deregulated metabolism. The long suffering lipid field is gaining reputation and respect as evidenced through the Center of Biomedical Research Excellence in Lipidomics and Pathobiology (COBRE), Lipid MAPS (Metabolites And Pathways Strategy) Consortium sponsored by NIH, European initiatives for decoding the lipids through genomic approaches, and Genomics of Lipid-associated Disorder (GOLD) project initiated by Austrian government. This review attempts to provide an overview of the lipid imbalances associated with neurological disorders (Alzheimer's, Parkinson's; Niemann-Pick; Multiple sclerosis, Huntington, amyotrophic lateral sclerosis, schizophrenia, bipolar disorders and epilepsy) and CNS injury (Stroke, traumatic brain injury; and spinal cord injury) and a few provocative thoughts. Lipidomic analyses along with RNA silencing will provide new insights into the role of lipid intermediates in cell signaling and hopefully open new avenues for prevention or treatment options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rao, A. M., Hatcher, J. F., Larsen, E. C., Chen, X., Sun, D., & Tsao, F. H. C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m512112200 · Cited by 123
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
A comprehensive classification system for lipids
Fahy, E., Subramaniam, S., Brown, H. A., Glass, C. K., Merrill, A. H., Murphy, R. C., Raetz, C. R. H., Russell, D. W., Seyama, Y., Shaw, W., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.e400004-jlr200 · Cited by 1,699
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
The emerging field of lipidomics
Wenk, M. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1776 · Cited by 1,330
Role of cholesterol and lipid organization in disease
Maxfield, F. R., & Tabas, I. (2005) · Nature · doi:10.1038/nature04399 · Cited by 1,293
Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D., Haroutunian, V., & Fienberg, A. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081071198 · Cited by 1,192
UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALS
Bruijn, L. I., Miller, T. M., & Cleveland, D. W. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144244 · Cited by 1,185
Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts
Ehehalt, R., Keller, P., Haass, C., Thiele, C., & Simons, K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207113 · Cited by 932
Clinical trials in head injury
Narayan, R. K., Michel, M. E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M. B., Bullock, M. R., Choi, S. C., Clifton, G. L., Contant, C. F., et al. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753754037 · Cited by 913
Lukiw, W. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25420 · Cited by 872
Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., Hardy, M., Gimenez, J. M., Chiang, N., Serhan, C. N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305841200 · Cited by 802
Tumor necrosis factor-alpha expression in ischemic neurons.
Liu, T., Clark, R. K., McDonnell, P. C., Young, P. R., White, R. F., Barone, F. C., & Feuerstein, G. Z. (1994) · Stroke · doi:10.1161/01.str.25.7.1481 · Cited by 797
The cell biology of lysosomal storage disorders
Futerman, A. H., & van Meer, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1423 · Cited by 796
Oddo, S., Billings, L., Kesslak, J. P., Cribbs, D. H., & LaFerla, F. M. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.003 · Cited by 780
Cyclooxygenase-2 (COX-2) in Inflammatory and Degenerative Brain Diseases
Minghetti, L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.901 · Cited by 779
Molecular targets in cerebral ischemia for developing novel therapeutics
Mehta, S. L., Manhas, N., & Raghubir, R. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.11.003 · Cited by 708
Oxidative stress in brain aging, neurodegenerative and vascular diseases: An overview
Mariani, E., Polidori, M. C., Cherubini, A., & Mecocci, P. (2005) · Journal of Chromatography B · doi:10.1016/j.jchromb.2005.04.023 · Cited by 680
Alzheimer’s disease: the cholesterol connection
Puglielli, L., Tanzi, R. E., & Kovacs, D. M. (2003) · Nature Neuroscience · doi:10.1038/nn0403-345 · Cited by 677
Sharon, R., Bar-Joseph, I., Frosch, M. P., Walsh, D. M., Hamilton, J. A., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00024-2 · Cited by 562
Anticonvulsant Mechanisms of the Ketogenic Diet
Bough, K. J., & Rho, J. M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.00915.x · Cited by 523
Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII)
Bialer, M., Johannessen, S. I., Kupferberg, H. J., Levy, R. H., Perucca, E., & Tomson, T. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.10.008 · Cited by 477
Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease
Horinouchi, K., Erlich, S., Perl, D. P., Ferlinz, K., Bisgaier, C. L., Sandhoff, K., Desnick, R. J., Stewart, C. L., & Schuchman, E. H. (1995) · Nature Genetics · doi:10.1038/ng0795-288 · Cited by 471
Loddick, S. A., & Rothwell, N. J. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00017 · Cited by 463
Modulation of inflammation in brain: A matter of fat
Farooqui, A. A., Horrocks, L. A., & Farooqui, T. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04371.x · Cited by 460
Neuroprotective and disease-modifying effects of the ketogenic diet
Gasior, M., Rogawski, M. A., & Hartman, A. L. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00009 · Cited by 445
Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin
Grimm, M. O. W., Grimm, H. S., Pätzold, A. J., Zinser, E. G., Halonen, R., Duering, M., Tschäpe, J.-A., Strooper, B. D., Müller, U., Shen, J., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1313 · Cited by 445
Antioxidant strategies in the treatment of stroke
Margaill, I., Plotkine, M., & Lerouet, D. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.003 · Cited by 405
Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia
Muralikrishna Adibhatla, R., & Hatcher, J. F. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.044 · Cited by 393
Self-citationWilliams, T. I., Lynn, B. C., Markesbery, W. R., & Lovell, M. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.06.004 · Cited by 392
Tumor necrosis factor receptor-mediated signaling pathways.
Heller, R. A., & Krönke, M. (1994) · The Journal of cell biology · doi:10.1083/jcb.126.1.5 · Cited by 387
Resolvins and protectins in the termination program of acute inflammation
Ariel, A., & Serhan, C. N. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.02.007 · Cited by 381
Neuroprotection and acute spinal cord injury: A reappraisal
Hall, E. D., & Springer, J. E. (2004) · NeuroRX · doi:10.1602/neurorx.1.1.80 · Cited by 379
Reactive oxygen species and the modulation of stroke
Crack, P. J., & Taylor, J. M. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.01.019 · Cited by 378
Farooqui, A. A., Ong, W.-Y., & Horrocks, L. A. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.7 · Cited by 368
Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden
Simpson, E. P., Henry, Y. K., Henkel, J. S., Smith, R. G., & Appel, S. H. (2004) · Neurology · doi:10.1212/wnl.62.10.1758 · Cited by 327
The silent treatment: siRNAs as small molecule drugs
Dykxhoorn, D. M., Palliser, D., & Lieberman, J. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302703 · Cited by 324
Lipid microarrays identify key mediators of autoimmune brain inflammation
Kanter, J. L., Narayana, S., Ho, P. P., Catz, I., Warren, K. G., Sobel, R. A., Steinman, L., & Robinson, W. H. (2006) · Nature Medicine · doi:10.1038/nm1344 · Cited by 317
Divide and Die: Cell Cycle Events as Triggers of Nerve Cell Death
Herrup, K., Neve, R., Ackerman, S. L., & Copani, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3347-04.2004 · Cited by 287
Götz, J., Streffer, J. R., David, D., Schild, A., Hoerndli, F., Pennanen, L., Kurosinski, P., & Chen, F. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001508 · Cited by 274
Wang, X., Yue, T.-L., Barone, F. C., White, R. F., Gagnon, R. C., & Feuerstein, G. Z. (1994) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815404 · Cited by 272
Future of neuroprotection for acute stroke: In the aftermath of the SAINT trials
Savitz, S. I., & Fisher, M. (2007) · Annals of Neurology · doi:10.1002/ana.21127 · Cited by 267
Involvement of inflammatory cytokines in central nervous system injury
Wang, C. X., & Shuaib, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00010-2 · Cited by 248
Matrix metalloproteinases and free radicals in cerebral ischemia
Jian Liu, K., & Rosenberg, G. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.033 · Cited by 230
Novel Metabolism of Docosahexaenoic Acid in Neural Cells
Kim, H.-Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700015200 · Cited by 219
Citicoline: pharmacological and clinical review, 2010 update.
Secades, J. J. (2011) · PubMed · Cited by 216
Cytidine 5?-Diphosphocholine (CDP-Choline) in Stroke and Other CNS Disorders
Adibhatla, R. M., & Hatcher, J. F. (2005) · Neurochemical Research · doi:10.1007/s11064-004-9681-8 · Cited by 193
Self-citationJellinger, K. A. (2004) · Current Opinion in Neurology · doi:10.1097/00019052-200412000-00012 · Cited by 192
Lipid and cholesterol trafficking in NPC
Mukherjee, S., & Maxfield, F. R. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.08.009 · Cited by 190
Lipids and lipidomics in brain injury and diseases
Adibhatla, R. M., Hatcher, J. F., & Dempsey, R. J. (2006) · The AAPS Journal · doi:10.1007/bf02854902 · Cited by 187
Self-citationCytosolic Phospholipase A2 Plays a Key Role in the Pathogenesis of Multiple Sclerosis-like Disease
Kalyvas, A., & David, S. (2004) · Neuron · doi:10.1016/s0896-6273(04)00003-0 · Cited by 185
Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease
Lane, R. M., & Farlow, M. R. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400486-jlr200 · Cited by 184
The endocannabinoid system in targeting inflammatory neurodegenerative diseases
Centonze, D., Finazzi-Agrò, A., Bernardi, G., & Maccarrone, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.004 · Cited by 182
Polyamine Oxidase and Acrolein as Novel Biochemical Markers for Diagnosis of Cerebral Stroke
Tomitori, H., Usui, T., Saeki, N., Ueda, S., Kase, H., Nishimura, K., Kashiwagi, K., & Igarashi, K. (2005) · Stroke · doi:10.1161/01.str.0000190004.36793.2d · Cited by 176
Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer’s disease
Delacourte, A., Sergeant, N., Champain, D., Wattez, A., Maurage, C.-A., Lebert, F., Pasquier, F., & David, J.-P. (2002) · Neurology · doi:10.1212/wnl.59.3.398 · Cited by 168
Lipid imbalance in the neurological disorder, Niemann‐Pick C disease
Vance, J. E. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.008 · Cited by 151
Klotz, U. E. (2007) · Clinical Pharmacokinetics · doi:10.2165/00003088-200746040-00001 · Cited by 151
Marušić, S., Leach, M. W., Pelker, J. W., Azoitei, M. L., Uozumi, N., Cui, J., Shen, M. W. H., DeClercq, C., Miyashiro, J. S., Carito, B. A., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050665 · Cited by 148
Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease
Moses, G. S. D., Jensen, M. D., Lue, L., Walker, D. G., Sun, A. Y., Simonyi, Á., & Sun, G. Y. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-28 · Cited by 147
Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease
Schwab, C., Hosokawa, M., & McGeer, P. L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.03.016 · Cited by 144
Ethyl-EPA in Huntington disease
Puri, B. K., Leavitt, B. R., Hayden, M. R., Ross, C. A., Rosenblatt, A., Greenamyre, J. T., Hersch, S. M., Vaddadi, K. S., Sword, A., Horrobin, D. F., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000169025.09670.6d · Cited by 141
Miranda, S. R. P., He, X., Simonaro, C. M., Gátt, S., Dagan, A., Desnick, R. J., & Schuchman, E. H. (2000) · The FASEB Journal · doi:10.1096/fj.00-0014com · Cited by 140
Docosahexaenoic Acid Complexed to Albumin Elicits High-Grade Ischemic Neuroprotection
Belayev, L., Marcheselli, V. L., Khoutorova, L., Turco, E., Busto, R., Ginsberg, M. D., & Bazan, N. G. (2004) · Stroke · doi:10.1161/01.str.0000149620.74770.2e · Cited by 134
祐幸, 齋., Wang, H., Mace, B. E., Leinenweber, S., Warner, D. S., Bennett, E. R., Vitek, M. P., McKenna, S., & Laskowitz, D. T. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.014 · Cited by 133
Savitz, S. T. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.003 · Cited by 133
Ariza, M., Pueyo, R., Matarín, M. D. M., Junqué, C., Mataró, M., Clemente, I., Moral, P., Poca, M. A., Garnacho, A., & Sahuquillo, J. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.085167 · Cited by 128
Clifford, J. J., Drago, J., Natoli, A. L., Wong, J. Y. F., Kinsella, A., Waddington, J. L., & Vaddadi, K. S. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00409-2 · Cited by 123
Citicoline mechanisms and clinical efficacy in cerebral ischemia
Rao, A. M., & Hatcher, J. F. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10403 · Cited by 122
Self-citationShort interfering RNA (siRNA): tool or therapeutic?
Cejka, D., Losert, D., & Wacheck, V. (2005) · Clinical Science · doi:10.1042/cs20050162 · Cited by 118
Maccarrone, M., Battista, N., & Centonze, D. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.11.006 · Cited by 118
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease mice
Stack, E. C., Smith, K. M., Ryu, H., Cormier, K., Chen, M., Hagerty, S. W., Del Signore, S. J., Cudkowicz, M. E., Friedlander, R. M., & Ferrante, R. J. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.11.002 · Cited by 114
Complex Genetics of Amyotrophic Lateral Sclerosis
Kunst, C. B. (2004) · The American Journal of Human Genetics · doi:10.1086/426001 · Cited by 113
Citicolina: revisión farmacológica y clínica, actualización 2022
Secades, J. J., & Gareri, P. (2022) · Revista de Neurología · doi:10.33588/rn.75s05.2022311 · Cited by 110
Samadi, P., Grégoire, L., Rouillard, C., Bédard, P. J., Paolo, T. D., & Lévesque, D. (2006) · Annals of Neurology · doi:10.1002/ana.20738 · Cited by 105
Bazan, N. G. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9064-6 · Cited by 102
Relevance of oxidative injury in the pathogenesis of motor neuron diseases
Agar, J. N., & Durham, H. D. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310011278 · Cited by 95
Mahmood, A., Lu, D., Qu, C., Goussev, A. V., & Chopp, M. (2007) · Neurosurgery · doi:10.1227/01.neu.0000255346.25959.99 · Cited by 94
Cholesterol, statins and dementia
Wolozin, B. L. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200412000-00007 · Cited by 92
Lin, T., Wang, Q., Simonyi, Á., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02540.x · Cited by 88
Integration of cytokine biology and lipid metabolism in stroke
Rao, A. M., Dempsy, R., & Hatcher, J. F. (2007) · Frontiers in bioscience · doi:10.2741/2759 · Cited by 87
Self-citationCyclooxygenase-2 Does Not Contribute to Postischemic Production of Reactive Oxygen Species
Kunz, A. B., Anrather, J., Zhou, P., Orio, M., & Iadecola, C. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600369 · Cited by 86
Liu, X., Lovell, M. A., & Lynn, B. C. (2005) · Analytical Chemistry · doi:10.1021/ac050624t · Cited by 84
Inhibitors of Secretory Phospholipase A2 Group IIA
Reid, R. C. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774462860 · Cited by 82
Bioactive lipids in schizophrenia
Berger, G. E., Smesny, S., & Amminger, G. P. (2006) · International Review of Psychiatry · doi:10.1080/09540260600583072 · Cited by 80
Role of Cytokines in Neurological Disorders
Aarli, J. A. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456918 · Cited by 76
Association of APOE e4 and cerebrovascular pathology in traumatic brain injury
Smith, C. S. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074617 · Cited by 69
Antioxidants in Multiple Sclerosis: Do They Have a Role in Therapy?
Carlson, N. G., & ROSE, J. W. (2006) · CNS Drugs · doi:10.2165/00023210-200620060-00001 · Cited by 68
Jiang, J., Borisenko, G. G., Osipov, A. N., Martin, I., Chen, R., Shvedova, A. A., Sorokin, A., Tyurina, Y. Y., Potapovich, A. I., Tyurin, V. A., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02577.x · Cited by 68
Dementia after traumatic brain injury
STARKSTEIN, S. E., & Jorge, R. E. (2005) · International Psychogeriatrics · doi:10.1017/s1041610205001973 · Cited by 67
A New Look at the Second-Generation Antiepileptic Drugs: A Decade of Experience
LaRoche, S. M. (2007) · The Neurologist · doi:10.1097/01.nrl.0000256353.14257.7c · Cited by 66
Aging of the brain, neurotrophin signaling, and Alzheimer's disease: Is IGF1-R the common culprit?
Puglielli, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.010 · Cited by 61
Amyotrophic lateral sclerosis: recent advances and future therapies
Nirmalananthan, N., & Greensmith, L. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000187248.21103.c5 · Cited by 60
Traumatic brain injury induces biphasic upregulation of ApoE and ApoJ protein in rats
Iwata, A., Browne, K. D., Chen, X., Yuguchi, T., & Smith, D. H. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20607 · Cited by 59
Transglutaminase Is Linked to Neurodegenerative Diseases
Muma, N. A. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31803d3b02 · Cited by 59
CDP-choline liposomes provide significant reduction in infarction over free CDP-choline in stroke
Rao, A. M., Hatcher, J. F., & Türeyen, K. (2005) · Brain Research · doi:10.1016/j.brainres.2005.07.067 · Cited by 54
Self-citationDo statins slow down Alzheimer's disease? A review
Caballero, J., & Nahata, M. (2004) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2004.00560.x · Cited by 53
Cunningham, T. J., Yao, L., Oetinger, M., et al. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-26 · Cited by 53
Eicosanomics: targeted lipidomics of eicosanoids in biological systems
Balazy, M. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.03.003 · Cited by 50
Senn, C., Hangartner, C., Moes, S., Guerini, D., & Hofbauer, K. G. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.021 · Cited by 44
Aktaş, O., Waiczies, S., & Zipp, F. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.026 · Cited by 43
Alzheimer peptides perturb lipid-regulating enzymes
Mattson, M. P., Cutler, R. G., & Jo, D. (2005) · Nature Cell Biology · doi:10.1038/ncb1105-1045 · Cited by 39
Larsen, E. C., Hatcher, J. F., & Adibhatla, R. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.02.022 · Cited by 37
Self-citationMandavilli, A. (2006) · Nature Medicine · doi:10.1038/nm0706-747 · Cited by 37
The ketogenic diet in children with epilepsy
Papandreou, D., Pavlou, E., Kalimeri, E., & Mavromichalis, I. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20051591 · Cited by 37
Role of caspases in TNF‐mediated regulation of cPLA2
Krönke, M., & Adam‐Klages, S. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03407-5 · Cited by 34
α-Synuclein oligomerization: a role for lipids?
Welch, K., & Yuan, J. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.001 · Cited by 34
Can statins put the brakes on Alzheimer’s disease?
Whitfield, J. F. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.12.1479 · Cited by 32
In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission
Degroot, A., & Nomikos, G. G. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.11.001 · Cited by 31
Advances in the Pharmacologic Management of Early Parkinson Disease
Hauser, R., & Zesiewicz, T. (2007) · The Neurologist · doi:10.1097/01.nrl.0000256433.15481.eb · Cited by 31
Kuller, L. H. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0012-9 · Cited by 31
The endocannabinoid system in neurodegeneration.
Battista, N., Fezza, F., Finazzi‐Agrò, A., et al. (2007) · PubMed · Cited by 25
Hillard, C. J. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.004 · Cited by 20
Corticosteroids in TBI: Is the Story Closed?
Rigg, J. L., & ZAFONTE, R. D. (2006) · Journal of Head Trauma Rehabilitation · doi:10.1097/00001199-200605000-00010 · Cited by 7
Chapter 3 The lipid hypothesis of schizophrenia
Horrobin, D. F. (2002) · New comprehensive biochemistry · doi:10.1016/s0167-7306(02)35032-4 · Cited by 6
Cited by
Dunn, W. B., Broadhurst, D. I., Atherton, H. J., Goodacre, R., & Griffin, J. L. (2011) · Chem. Soc. Rev. · doi:10.1039/b906712b · Cited by 860
Adibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480
Self-citationAltered Lipid Metabolism in Brain Injury and Disorders
Adibhatla, R. M., & Hatcher, J. F. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_9 · Cited by 401
Self-citationCristofori, I., Cohen-Zimerman, S., & Grafman, J. (2019) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-804281-6.00011-2 · Cited by 378
Flavonoids and brain health: multiple effects underpinned by common mechanisms
Spencer, J. P. E. (2009) · Genes & Nutrition · doi:10.1007/s12263-009-0136-3 · Cited by 330
Metadata
- Authors
- Adibhatla, R. M., & Hatcher, J. F.
- Venue
- Future Lipidology
- Publisher
- Informa UK Limited
- Published
- 2007-08-01
- Volume
- 2
- Issue
- 4
- Pages
- 403-422
- ISSN
- 1746-0875 (ISSN-L)
- OpenAlex
- W2117886681
- Cited by
- 270
- References
- 115
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.